Anne-Marie Law
Nessuna posizione attualmente
Storia della carriera di Anne-Marie Law
Precedenti posizioni note di Anne-Marie Law
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Ufficiale delle Risorse Umane | 05/06/2017 | 12/02/2019 |
| Corporate Officer/Principal | 12/02/2019 | 21/08/2020 | |
| HYATT HOTELS CORPORATION | Ufficiale delle Risorse Umane | 01/10/2016 | 05/09/2017 |
| McKesson Specialty Care Solutions | Ufficiale delle Risorse Umane | 01/04/2009 | 01/12/2010 |
| BAXALTA INC | Ufficiale delle Risorse Umane | 01/01/2015 | - |
| VERISIGN. INC. | Ufficiale delle Risorse Umane | 01/05/2007 | - |
Formazione di Anne-Marie Law
| University of Leicester | Undergraduate Degree |
| National College of Ireland | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Regno Unito | 2 |
| Irlanda | 2 |
Posizioni
| Human Resources Officer | 5 |
| Undergraduate Degree | 2 |
| Corporate Officer/Principal | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
| Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| VERISIGN. INC. | Technology Services |
| HYATT HOTELS CORPORATION | Consumer Services |
| Aziende private | 3 |
|---|---|
| McKesson Specialty Care Solutions | |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Anne-Marie Law
- Esperienza
